Paratonia in Dementia: A Systematic Review
Hans Drenth1,2, Sytse Zuidema3, Ivan Bautmans4
1Research group Healthy Ageing, Allied Health Care and Nursing, University of Applied Sciences Groningen, Groningen, the Netherlands.
Journal of Alzheimer'S Disease : JAD
|November 13, 2020
Summary
Paratonia, a common motor abnormality in dementia, is poorly understood. This review synthesizes current knowledge on paratonia, highlighting limited research and advocating for increased study to improve dementia care.
Area of Science:
- Neurology
- Geriatrics
- Physical Therapy
Background:
- Paratonia is a motor abnormality frequently observed in individuals with dementia.
- Despite its prevalence, paratonia remains underrecognized by clinicians and researchers.
Purpose of the Study:
- To conduct a systematic literature review on paratonia.
- To define, understand the pathogenesis, diagnose, and identify interventions for paratonia.
- To propose a future research agenda for paratonia.
Main Methods:
- Systematic literature search of Embase, PubMed, CINAHL, and Cochrane CENTRAL databases up to December 2019.
- Data extraction and risk of bias assessment by two independent reviewers.
- Analysis of study design, population, diagnosis, assessment, pathogenesis, and interventions.
Main Results:
- Thirty-five studies met the inclusion criteria.
- The review identified clinical criteria for paratonia and discussed its pathogenesis, assessment methods, and diagnosis.
- Interventions and severity of paratonia were also examined.
Conclusions:
- This review summarizes current knowledge on paratonia and its underlying mechanisms.
- Research on paratonia is limited but has shown an increase in the last decade.
- Further research is crucial to advance understanding and management of paratonia in dementia.
More Related Videos
14:47Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
Published on: April 21, 2023
3.4K
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.4K
Related Concept Videos
01:15Parkinson's Disease: Overview
1.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.3K
01:24Parkinson's Disease: Treatment
777
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
777
01:37Neural Regulation
42.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.4K
01:26Alzheimer's Disease: Overview
1.3K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.3K
01:30Dementia
391
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
391
01:22Alzheimer's Disease: Treatment
604
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
604